Xspray
Xspray Pharma's CEO: "XS003 shows that we are building a powerhouse – Dasynoc is just the beginning"
Xspray Pharma is now taking the next step in its strategy to build a powerhouse in protein kinase inhibitors. After Dasynoc, which is awaiting FDA approval...
Emission
Xspray carries out rights issue of SEK 130 million
Xspray backs down after delayed FDA application
The submission of Xspray Pharma's updated FDA application for Dasynoc...
The news sweep Wednesday 4 December
Alligator Bioscience
Capital injection to bring Xspray to market
Xspray Pharma is in the final stages of preparations...
The news sweep Thursday 14 November
Cereno Scientific
The news sweep Wednesday 6 November
From Seed to Success 2024
News roundup Tuesday, December 13
The latest from BioStock
The news sweep Friday 4 November
The latest from BioStock
News roundup Friday, May 6
BioStock Life Science Spring Summit
News roundup Thursday, August 13
Isofol
News roundup Monday, June 22
Newsletter